首页|黄芪复方制剂供试品溶液制备方法优化

黄芪复方制剂供试品溶液制备方法优化

扫码查看
目的 优化黄芪复方制剂供试品溶液的制备方法。方法 以提取溶剂为影响因素,以扶正强筋片样品中黄芪甲苷含量为考察指标,优选供试品溶液制备方法。并以此方法对 4 种市售黄芪复方制剂(前列通片、复方石韦片、芪明颗粒、复方血栓通胶囊)进行验证。结果 优选方法为在药典方法基础上,用氨试液-水-水饱和的正丁醇(10∶30∶50,V/V/V)混合溶剂进行加热回流提取(含量测定结果为 1。09mg/g,RSD为 1。93%)。4种复方制剂测得黄芪甲苷含量为药典方法的 1。8~2。6倍,RSD介于 1。61%~4。73%。结论 该方法快捷高效,专属性、重复性良好,降低了系统误差,结果准确,可用于黄芪复方制剂供试品溶液的制备。
Optimization of the Preparation for the Test Solution of Huangqi Compound Preparation
Objective To optimize the preparation method of the test solution of Huangqi Compound Preparation.Methods The preparation method of the test solution was optimized with the extraction solvent as the influencing factor and the content of astragaloside Ⅳ in the Fuzheng Qiangjin Tablets as the investigation indicator.The above optimal method was verified with four commercial Huangqi Compound Preparations(Qianlietong Tablets,Compound Shiwei Tablets,Qiming Granules,Compound Xueshuantong Capsules)as the test subjects.Results The optimal method was that the ammonia test solution-water-water saturated n-butanol(10∶30∶50,V/V/V)was used for heating reflux extraction based on the method of Chinese Pharmacopoeia;the content of astragaloside Ⅳ determined by the above method was 1.09 mg/g with an RSD of 1.93%.The content of astragaloside Ⅳ in four compound preparations determined by the above optimal method was in the range of 1.8 to 2.6 times higher than that determined by the method of Chinese Pharmacopoeia,with an RSD in the range of 1.61%to 4.73%.Conclusion This method is fast,efficient,specific,repeatable,accurate and has low systematical error,which can be used for the preparation of the test solution of Huangqi Compound Preparation.

Astragali Radixcompound preparationastragaloside Ⅳtest solutionHPLCcontent determination

冉京燕、谢委、谢雪佳、汪秋兰、熊微、方建国、王文清

展开 >

华中科技大学同济医学院附属同济医院,湖北 武汉 430030

黄芪 复方制剂 黄芪甲苷 供试品溶液 高效液相色谱法 含量测定

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(10)
  • 16